2.Immunophenotypings of malignant epithelial mesothelioma and their roles in the differential diagnosis.
Journal of Huazhong University of Science and Technology (Medical Sciences) 2004;24(2):112-115
To investigate the immunophenotypings of malignant epithelial mesothelioma (MEM), and to seek the valuable markers in distinguishing peritoneal MEM from peritoneal metastatic ovarian adenocarcinoma (OA) and colorectal adenocarcinoma (CA), immunohistochemical SP method was used to detect expressions of HBME-1, E-cadherin, CA19-9, MOC-31 and CK7 in paraffin-embedded tissues of 18 cases of MEM, 20 OA and 20 CA. The results showed that there was a significant difference in the expressions of E-cadherin, CA19-9 and MOC-31 between MEM and OA group (P<0.05). Similarly, the difference in the expression of HBME-1, E-cadherin, CA19-9, MOC-31 and CK7 between MEM and CA groups is significant (P<0.05). These results indicate that HBME-1 could be used as a positive marker in distinguishing MEM from CA. E-cadherin, CA19-9 and MOC-31 are considered to be useful negative markers in diagnostic distinction between MEM and metastatic adenocarcinomas, including OA and CA. CK7 is the best positive marker in distinguishing MEM from CA, but this marker appears to be valueless in discriminating MEM from OA.
Adenocarcinoma
;
diagnosis
;
pathology
;
Colorectal Neoplasms
;
complications
;
diagnosis
;
pathology
;
Cystadenocarcinoma, Mucinous
;
diagnosis
;
pathology
;
Cystadenocarcinoma, Serous
;
diagnosis
;
pathology
;
Diagnosis, Differential
;
Female
;
Humans
;
Immunophenotyping
;
Male
;
Mesothelioma
;
diagnosis
;
etiology
;
pathology
;
Ovarian Neoplasms
;
complications
;
diagnosis
;
pathology
;
Peritoneal Neoplasms
;
diagnosis
;
etiology
;
pathology
3.Primary Retroperitoneal Mucinous Cystadenocarcinoma: A Case Report and Review of the Literature.
Sun Ah LEE ; Sung Hwa BAE ; Hun Mo RYOO ; Hyun Young JUNG ; Saet Byul JANG ; Yoon Seup KUM
The Korean Journal of Internal Medicine 2007;22(4):287-291
Primary retroperitoneal mucinous cystadenocarcinoma is a rare tumor. Only about 30 such cases have been reported in the worldwide literature, and a few Korean cases have been reported. The pathogenesis is not clear, and coelomic metaplasia of the retroperitoneal mesothelium has gained wide support. There is no consensus on the appropriate treatment, but surgical exploration is needed for the diagnosis and treatment, and adjuvant chemotherapy may be recommended following complete surgical excision. The long-term prognosis has not been established. We report here on a 32-year-old woman who was diagnosed as having a retroperitoneal mucinous cystadenocarcinoma with mural nodules of sarcomatoid change. Tumor excision and adjuvant chemotherapy were done and the patient is doing well without any evidence of recurrence at 42 months postoperatively.
Adult
;
Cystadenocarcinoma, Mucinous/*diagnosis/pathology/surgery
;
Female
;
Humans
;
Retroperitoneal Neoplasms/*diagnosis/pathology/surgery
5.Cytologic Findings of Cervicovaginal Smears in Women with Uterine Papillary Serous Carcinoma.
Ji Young PARK ; Hye Sun KIM ; Sung Ran HONG ; Yi Kyeong CHUN
Journal of Korean Medical Science 2005;20(1):93-97
The goal of this study was to evaluate the cytomorphologic features of histologically confirmed uterine papillary serous carcinomas (UPSC) of the endometrium. We reviewed cervicovaginal smears from 12 patients with UPSC who had done their cervical smears at six months to a year earlier before the time of diagnosis; nine smears (75%) were diagnosed as positive for malignancy and three smears (25%) were diagnosed as negative. The cervical smears of patients with UPSC revealed frequent papillary clusters that were composed of large pleomorphic tumor cells with prominent nucleoli in a background of necrosis. Other findings revealed from the tests were relatively frequent single malignant cells and bare nuclei. Although the Pap smear is not a sensitive screening test for endometrial carcinoma, we could depend on it to reveal the cytologic features of UPSC which are fairly characteristic and reliable for a preoperative diagnosis of UPSC. Preoperative identification of this poor prognostic variant of endometrial carcinoma may influence the surgical management of these cases and the choice of adjuvant therapy.
Adenocarcinoma/diagnosis/pathology
;
Adult
;
Aged
;
Carcinoma
;
Carcinoma, Squamous Cell/diagnosis/pathology
;
Cystadenocarcinoma, Papillary/*diagnosis/*pathology
;
Cystadenocarcinoma, Serous/*diagnosis/*pathology
;
Diagnosis, Differential
;
Female
;
Humans
;
Middle Aged
;
Necrosis
;
Prognosis
;
Uterine Neoplasms/*diagnosis/*pathology
;
*Vaginal Smears
6.Bile Duct Cystadenocarcinoma.
The Korean Journal of Hepatology 2007;13(1):108-111
No abstract available.
Bile Duct Neoplasms/diagnosis/*pathology/surgery
;
Bile Ducts/*pathology/surgery
;
Cystadenocarcinoma/diagnosis/*pathology/surgery
;
Female
;
Humans
;
Middle Aged
;
Prognosis
7.Application of immunohistochemistry in differential diagnosis of endometrial carcinoma.
Chinese Journal of Pathology 2012;41(11):784-788
Adenocarcinoma, Clear Cell
;
diagnosis
;
metabolism
;
pathology
;
Adenocarcinoma, Mucinous
;
diagnosis
;
metabolism
;
pathology
;
Biomarkers, Tumor
;
metabolism
;
Carcinoma, Endometrioid
;
diagnosis
;
metabolism
;
pathology
;
Cystadenocarcinoma, Serous
;
diagnosis
;
metabolism
;
pathology
;
Diagnosis, Differential
;
Endometrial Neoplasms
;
diagnosis
;
metabolism
;
pathology
;
Female
;
Humans
;
Immunohistochemistry
;
Uterine Cervical Neoplasms
;
diagnosis
;
metabolism
;
pathology
8.Biliary Cystic Neoplasm: Biliary Cystadenoma and Biliary Cystadenocarcinoma.
The Korean Journal of Gastroenterology 2006;47(1):5-14
Biliary cystic tumors, such as cystadenoma and cystadenocarcinoma, are rare cystic tumors of liver accounting for fewer than 5% of all intrahepatic cysts of biliary origin. Most biliary cystic tumors arise from intrahepatic bile duct and 10-20% arise from extrahepatic bile duct like common hepatic duct, common bile duct, and gallbladder. The first case report of biliary cystic neoplasm in Korea dated back to 1975 by Bae et al, and over 40 cases of cystadenoma and 35 cases of cystadenocarcinoma were reported since then. These tumors usually present in middle-aged women with a mean age of 50 years. Biliary cystadenomas are lined by single layer of cuboidal or columnar epithelium and are very often multilocular with septal or papillary foldings. Over 80% of cystadenoma have dense mesenchymal stroma composed of dense spindle cells, like ovary. The epithelial lining of cystadenocarcinoma exhibits cellular atypia, mitotic activity, and infiltrative growth, but part of lining epithelium retain the feature of cystadenoma, which support the adenoma-carcinoma sequence. The size of tumors varies from 1.5 to 35 cm. Many patients are asymptomatic, except for the presence of palpable mass. When symptoms are present, they include epigastric or right upper quadrant pain or jaundice by enlarged mass. Biliary cystic tumor should be considered when a single or multilocular cystic lesion with papillary infoldings is detected in the liver by computed tomogram (CT) or ultrasound (US). Cystic wall and internal foldings can be seen enhanced by enhanced CT. US reveals a hypoechoic cystic mass with echogenic septation or papillary infoldings. Cystadenocarcinoma should be suspected when there is elevated mass or nodule in the wall or foldings, or thickened cystic wall on CT or US. But it is extremely difficult to differentiate between cystadenoma and cystadenocarcinoma by imaging alone. Increased tumor markers, carcinoembryonic antigen and carbohydrate antigen 19-9, in serum or cystic fluid have been reported in biliary cystic tumor. But tumor markers cannot distinguish cystadenocarcinoma from cystadenoma or both from other cystic lesions of liver. Malignant cells are not usually recovered in patients with cystadenocarcinoma who underwent cystic fluid cytology before and during surgery. The treatment of choice is radical excision of the mass by means of lobectomy or wide tumor excision. Aspiration, marsupialization, and drainage must be avoided. Inadequate excision of both cystadenoma and cystadenocarcinoma may lead to recurrence. Prognosis after complete excision is excellent.
Adult
;
Aged
;
*Biliary Tract Neoplasms/diagnosis/pathology/surgery
;
*Cystadenocarcinoma/diagnosis/pathology/surgery
;
*Cystadenoma/diagnosis/pathology/surgery
;
Female
;
Humans
;
Male
;
Middle Aged
10.Ovarian needle aspiration in the diagnosis and management of ovarian masses.
Kimberly NAGAMINE ; Jordan KONDO ; Ricky KANESHIRO ; Pamela TAUCHI-NISHI ; Keith TERADA
Journal of Gynecologic Oncology 2017;28(4):e40-
OBJECTIVE: Ovarian needle aspiration and biopsy (ONAB) may be employed for pretreatment diagnosis of ovarian malignancies or intraoperatively to facilitate removal of ovarian masses. However, there is reluctance to utilize this procedure due to potential cyst rupture or seeding of malignant cells. The objective of this study was to examine the efficacy of ONAB over a 13-year period at our institution. METHODS: Between 2000 and 2013, all ONAB specimens were identified from the Queen's Medical Center Pathology Department database. All cytologic specimens were reviewed and correlated with histopathologic findings. A retrospective chart review was conducted to retrieve data on clinical course and treatment. RESULTS: This study identified 144 cases of ovarian masses sampled by aspiration or needle biopsy between 2000 and 2013. Ninety-two (64%) cases had corresponding histopathology, 84 (91%) of which were obtained concomitantly. On histology, 12 (13%) cases were malignant and 80 (87%) benign. Three false negative cases were noted; 2 serous borderline tumors and 1 mucinous cystadenocarcinoma. These were sampling errors; no diagnostic tumor cells were present in the aspirates. Sensitivity and specificity of ONAB in the detection of malignancy were 75% and 100%, respectively. The positive and negative predictive values were 100% and 96%, respectively. CONCLUSION: ONAB represents a valuable tool in the diagnosis of malignancy and treatment of ovarian masses. In our study, it was highly specific, with excellent positive and negative predictive value.
Biopsy
;
Biopsy, Needle
;
Cystadenocarcinoma, Mucinous
;
Diagnosis*
;
Needles*
;
Ovarian Neoplasms
;
Pathology
;
Retrospective Studies
;
Rupture
;
Selection Bias
;
Sensitivity and Specificity